Osteoarthritis Treatment MarketSize and Trends

Osteoarthritis as one of the most prevalent chronic diseases across the globe

Centers for Disease Control and Prevention, 2016, reveals that there are over 100 types of arthritis and the most common form is osteoarthritis. Arthritis affected around 54.4 million adults in the U.S. during 2013- 2015. According to the Arthritis Foundation, 2014, over US$ 156 billion are dedicated annually in lost wages and medical expenses towards treatment of arthritis. Moreover, Barbour 2017 states that arthritis affects 1 in every 4 adults in U.S. The Arthritis Foundation also reveals that out of the 54.4 million arthritic patients in the U.S., around 30.8 million suffered from osteoarthritis, in 2015. These key stats provide direct growth opportunities to the key players involved in the global osteoarthritis treatment market.

The global osteoarthritis treatment market is segmented on the basis of medications, therapies, end-user, and geography.

Based on the therapies, the global osteoarthritis treatment market is segmented into:

Non- Pharmacological Therapy
Pharmacological Therapy
Surgical Treatment

Market Trends

The global osteoarthritis treatment market is characterized by the adoption of new and effective treatment options, increased research and development activities, and a rise in awareness among patients. With the introduction of novel therapies and better patient outcomes, the market is projected to witness significant growth in the foreseeable future. Furthermore, the demand for these treatments is further fueled by the high prevalence of osteoarthritis and the necessity for pain management and improved quality of life for patients.